spacer
home > ict > summer 2018 > protecting privacy
PUBLICATIONS
International Clinical Trials

Protecting Privacy

ICT: Would you say that attitudes towards data protection are hardening? If so, why?

Dr Andrew Rut: Data privacy is one of the most contentious issues of our time. Global attitudes towards the protection and ownership of personal data are toughening, and this is reflected in increased regulation. For example, the EU’s General Data Protection Regulation (GDPR), which was introduced in May 2018, expands existing rules in areas such as patient consent and imposes tough penalties for noncompliance.

The shift is happening because, while new technologies have enabled the capture of data at an unprecedented volume and rate, adequate systems to protect individuals’ personal information have not always developed in step. High-profile data breaches − such as SingHealth, where 1.5 million healthcare patients, including the Singaporean prime minister, had their personal data leaked − have raised awareness of the huge value of data and the need for increasingly robust security measures to protect it (1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Andrew Rut is CEO and Co-Founder of MyMeds&Me: a provider of Reportum. Andrew has deep expertise in pharmacovigilance, as well as the emerging challenges of data privacy, participating in numerous conferences and benchmarking initiatives. He is a trained physician who has held leadership roles spanning drug discovery and development within GSK, working across three continents: the US, Europe, and Asia-Pacific. He was previously Head of Safety at GSK and the EU Qualified Person Responsible for Pharmacovigilance, where he drove significant innovation and streamlining into the organisation.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Drive for generics sees Korea increasingly attractive to international pharma

Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.
More info >>

White Papers
 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement